Medtronic (NYSE:MDT) announces the commercial availability of the MiniMed Mio Advance infusion set to all Medtronic insulin pump users in the U.S.
The company says the new set can be inserted in only four steps with one hand while enabling more insertion sites on the body such as the lower back or back of the arm.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.